Country: United States
Language: English
Source: NLM (National Library of Medicine)
ERYTHROMYCIN STEARATE (UNII: LXW024X05M) (ERYTHROMYCIN - UNII:63937KV33D)
PD-Rx Pharmaceuticals, Inc.
ERYTHROMYCIN STEARATE
ERYTHROMYCIN 250 mg
ORAL
PRESCRIPTION DRUG
To reduce the development of drug-resistant bacteria and maintain the effectiveness of ERYTHROCIN ® STEARATE Film-coated tablets and other antibacterial drugs, ERYTHROCIN ® STEARATE Film-coated tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ERYTHROCIN ® STEARATE tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below: Upper respiratory tract infections of mild to moderate degree caused by Streptococcus pyogenes ; Streptococcus pneumoniae ; Haemophilus influenzae (when used concomitantly with adequate
ERYTHROCIN ® STEARATE Film-coated Tablets (erythromycin stearate tablets, USP) are supplied in the following strengths and packages. ERYTHROCIN ® STEARATE Film-coated, 250 mg pink tablets imprinted with the Product Code designation ES: Bottles of 4 NDC 55289-112-04 Bottles of 10 NDC 55289-112-10 Bottles of 15 NDC 55289-112-15 Bottles of 20 NDC 55289-112-20 Bottles of 28 NDC 55289-112-28 Bottles of 40 NDC 55289-112-40 Bottles of 56 NDC 55289-112-56 Bottles of 100 NDC 55289-112-01 Bottles of 120 NDC 55289-112-98 Store below 86°F (30°C).
Abbreviated New Drug Application
ERYTHROCIN STEARATE- ERYTHROMYCIN STEARATE TABLET, FILM COATED PD-RX PHARMACEUTICALS, INC. ---------- ERYTHROCIN STEARATE ERYTHROMYCIN STEARATE TABLETS, USP FILM-COATED TABLETS RX ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of ERYTHROCIN STEARATE Film-coated tablets and other antibacterial drugs, ERYTHROCIN STEARATE Film-coated tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION ERYTHROCIN STEARATE Film-coated tablets (erythromycin stearate tablets, USP) are an antibacterial product containing the stearate salt of erythromycin in a unique film coating. Erythromycin is produced by a strain of _Saccharopolyspora erythraea _(formerly _Streptomyces erythraeus_) and belongs to the macrolide group of antibiotics. It is basic and readily forms salts with acids. Erythromycin is a white to off-white powder, slightly soluble in water, and soluble in alcohol, chloroform, and ether. Erythromycin stearate is known chemically as erythromycin octadecanoate. The molecular formula of erythromycin stearate is C H NO ∙ C H O , and the molecular weight is 1018.43. The structural formula is: INACTIVE INGREDIENTS 250 mg tablet: Cellulosic polymers, corn starch, D&C Red No. 7, polacrilin potassium, polyethylene glycol, povidone, propylene glycol, sodium carboxymethylcellulose, sodium ® ® ® ® 37 67 13 18 36 2 citrate, sorbic acid, sorbitan monooleate and titanium dioxide. CLINICAL PHARMACOLOGY Orally administered erythromycin base and its salts are readily absorbed in the microbiologically active form. Interindividual variations in the absorption of erythromycin are, however, observed, and some patients do not achieve optimal serum levels. Erythromycin is largely bound to plasma proteins. After absorption, erythromycin diffuses readily into most body fluids. In the absence of meningeal inflammation, low concentrations are normally achieved in the spinal fluid but the passage of the drug across the blood-b Read the complete document